Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump announced a new agreement with drugmakers to reduce obesity drug prices.
Incident Details
The event on Thursday focused on a deal with Eli Lilly and Novo Nordisk to expand coverage and lower costs for their obesity treatments, Zepbound and Wegovy. David Ricks, CEO of Eli Lilly, noticed the executive's distress during his remarks and asked,
“Are you okay? Gordon, are you okay?”
Immediate Response
The man who collapsed was identified as Gordon Findlay, Global Brand Director for Novo Nordisk. Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, assisted Findlay as he fell to his knees. Health and Human Services Secretary was also present.
After the incident, the press was quickly asked to leave the room. About 30 minutes later, the press conference resumed with President Trump providing an update on Findlay's condition.
“President Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk, who passed out during an event where Trump made a statement on lowering drug prices.”
Summary
The collapse did not overshadow the announcement of the drug pricing deal, which aimed to make obesity treatments more affordable and accessible to patients.
Would you like the summary to be more formal or more conversational?